Ann Arbor, MI, June 25, 2024 – Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering. These powerful new kits include the myTXTL Pro Kit and the myTXTL Antibody/DS Kit, providing researchers with versatile tools to enhance throughput of their protein expression platforms, bringing discovery programs in both industry and academia to new heights. 

The myTXTL Pro Kit offers researchers a high yield solution for expression of non-disulfide bond-containing proteins and combines all the benefits of our previous kit offerings into one box for a simpler go-to solution. Whether you want to perform a simple library screen, CRISPR-Cas activity assays, or test gene circuits, the Pro Kit can serve multiple purposes in protein expression and synthetic biology.

In addition, the myTXTL Antibody/DS Kit is designed for robust expression of antibodies and disulfide bond-containing proteins, while also providing expression of proteins without disulfide bonds. It enables simple and scalable production of high-quality antibodies and other proteins, empowering researchers to explore diverse applications in biologics development, antibody screening, and protein engineering.

“The release of these kits marks a significant advancement in cell-free protein expression technology. Researchers can now produce analysis-ready yields of antibodies or target proteins within hours, simply by adding DNA,” said Alison Devault, Ph.D., Director of Product Management at Daicel Arbor Biosciences. “We are eager to collaborate with our customers to help them achieve their project objectives.” 

Designed with the user in mind, the myTXTL kits offer a streamlined and intuitive workflow, eliminating technical barriers and accelerating experimental timelines. These user-friendly features enable researchers to get their data sooner and drive innovation, confident in the robustness and reliability that these kits provide. 

The new myTXTL kits are now available for purchase, and Daicel Arbor Biosciences anticipates these kits to have a significant impact on antibody discovery, protein engineering, and synthetic biology research. To learn more about the myTXTL kits and their potential applications, visit the Daicel Arbor Biosciences website. 

About Daicel Arbor Biosciences

Daicel Arbor Biosciences is the trusted source for tools and services that accelerate genomics and protein research. We serve as a valued lab partner, actively working with you to achieve your project goals with great speed, efficiency, and ease. Your science is our passion.  

Ann Arbor, MI, March 26, 2024 – Daicel Arbor Biosciences, a leading provider of innovative genomic research solutions, has announced the launch of its new Library Preparation Kit for myBaits, which is designed to streamline the process of target enrichment for next-generation sequencing (NGS) applications.

The new kit offers users a simple and efficient solution for library preparation, enabling them to easily generate high-quality DNA libraries for use with myBaits target capture probes. The kit is compatible with a wide range of sample types, including samples from:

  • Human, plant, animal, fungus, virus, and bacteria samples
  • FFPE and cfDNA samples
  • Degraded, museum, herbarium, or historical samples

In addition to its compatibility with a variety of sample types, the new kit offers a number of other benefits to researchers. It includes a streamlined protocol that reduces the time required for library preparation, as well as a high level of flexibility, allowing users to modify the protocol to meet their specific needs.

“We are thrilled to introduce our new Library Preparation Kit for myBaits,” said Alison Devault, Ph.D., Director of Product Management at Daicel Arbor Biosciences. “This kit is the result of extensive research and development, and we believe it will be a game-changer for researchers who are working on target enrichment applications.”

The new kit is available for purchase now, and more information can be found on the Daicel Arbor Biosciences website.

About Daicel Arbor Biosciences

Daicel Arbor Biosciences is the trusted source for tools and services that accelerate genomics and synthetic biology research. We serve as a valued lab partner, actively working with you to achieve your project goals with great speed, efficiency, and ease. Your science is our passion.

a:8:{s:8:”location”;a:1:{i:0;a:1:{i:0;a:3:{s:5:”param”;s:9:”post_type”;s:8:”operator”;s:2:”==”;s:5:”value”;s:4:”page”;}}}s:8:”position”;s:6:”normal”;s:5:”style”;s:7:”default”;s:15:”label_placement”;s:3:”top”;s:21:”instruction_placement”;s:5:”label”;s:14:”hide_on_screen”;s:0:””;s:11:”description”;s:0:””;s:12:”show_in_rest”;b:0;}

a:8:{s:8:”location”;a:1:{i:0;a:1:{i:0;a:3:{s:5:”param”;s:9:”post_type”;s:8:”operator”;s:2:”==”;s:5:”value”;s:4:”page”;}}}s:8:”position”;s:6:”normal”;s:5:”style”;s:7:”default”;s:15:”label_placement”;s:3:”top”;s:21:”instruction_placement”;s:5:”label”;s:14:”hide_on_screen”;s:0:””;s:11:”description”;s:0:””;s:12:”show_in_rest”;i:0;}

Ann Arbor, MI, September 24, 2020 – Daicel Arbor Biosciences, a division of Chiral Technologies, Inc., announces the launch of their new line of myBaits Custom Methyl-Seq target capture kits. This new product line pairs an innovative methyl-seq probe design algorithm with a highly optimized target capture protocol to efficiently enrich target genes and markers of interest from converted methyl-seq NGS libraries. The hybridization capture technique significantly reduces per-sample sequencing costs compared to whole-genome bisulfite sequencing (WGBS) while preserving the essential strand-specific methylation signals.

myBaits Custom Methyl-Seq kits can be paired with either bisulfite or enzymatic-conversion workflows upstream of NGS library preparation, for seamless integration into your existing methyl-seq pipeline. All kits include the latest “v5” generation of myBaits hybridization and wash reagents, pairing best-ever performance with an easy-to-use protocol.

Introducing myBaits Custom Methyl-Seq hybridization capture kits, featuring:

Greater Savings Compared to WGBS
Specialized custom probe design algorithm
Optimized high-performance protocol
Dedicated support from expert scientists

“By offering this solution, Daicel Arbor Biosciences increases data and reduces sequencing costs by focusing next-generation sequencing coverage only on relevant genomic regions of interest,” said Alison Devault, Director of Genomics at Daicel Arbor Biosciences. “By sharpening this process, researchers using our product will be able to efficiently develop and expand their epigenetics research.”

Complimentary design and project development assistance will be provided from Daicel Arbor’s team of expert scientists to customers utilizing our DNA-Seq, RNA-Seq, or Methyl-Seq custom applications.

Learn more.

About Daicel Arbor Biosciences

Daicel Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

Contact for Daicel Arbor Biosciences:

Michele Gentile
mgentile@arborbiosci.daicel.com

Ann Arbor, MI (August 31, 2020) – Daicel Arbor Biosciences a division of Chiral Technologies, Inc., and leader in developing molecular biology research tools, announces an advance in the latest myBaits kit reagent chemistry and associated protocol referred to as myBaits Version 5. Daicel Arbor, a division of Chiral Technologies, Inc., is a leader in developing molecular biology research tools.

The myBaits v5 kit offers enhanced benefits including:

  • An updated chemistry with increased specificity and performance
  • Three application-specific protocols in a convenient manual

o             Standard (for most targeted seq applications)

o             High-Sensitivity (for rare, degraded, and/or divergent targets)

o             Long-Insert (for long-read NGS platforms)

  • Expanded experimental tips and recommendations

“We are proud to continue our tradition of supporting a broad range of research applications with tailored solutions for maximizing your experimental performance,” said Alison Devault, Director of Genomics at Daicel Arbor Biosciences. “Our advanced new chemistry offers maximum enrichment performance with an expanded, user-friendly manual.”

Complimentary design and project development assistance will be provided from Daicel Arbor’s team of expert scientists, as well as probe design for any custom DNA-Seq and RNA-Seq application. Contact our scientists today to get started on your next NGS project. Learn more by visiting https://arborbiosci.com/genomics/targeted-sequencing/mybaits/.

About Daicel Arbor Biosciences 

Daicel Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

About Chiral Technologies

Chiral Technologies, Inc., a subsidiary of Daicel Corporation, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. Learn more at www.chiraltech.com.